Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling

Phase 1positiveBA-101Positive

AI Analysis

Summary

Preclinical study demonstrated that BA-101, a selective inhibitor of neuronal nitric oxide synthase, suppressed neuroblastoma tumor growth in mice by blocking mTOR signaling. Results represent early-stage research not yet in clinical trials.

Clinical Trial Data

Phase

preclinical

Outcome Details

Preclinical study showed BA-101 selectively inhibits neuronal nitric oxide synthase and collapsed tumor growth in mice models of neuroblastoma

Importance:4/10

Sentiment:

0.60

neuroblastomamTOR signalingpreclinicaloncologyenzyme inhibitor

Related Companies

$TRAX

Read the original article

Published by GEN - Genetic Engineering & Biotech News on April 8, 2026 7:18 PM

Read Original